We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

191 hedge funds and large institutions have $2.99B invested in NPS PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 77 increasing their positions, 61 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 37

26% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 61

16% more call options, than puts

Call options by funds: $31.4M | Put options by funds: $27.1M

5% more funds holding

Funds holding: 182 → 191 (+9)

3% more capital invested

Capital invested by funds: $2.89B → $2.99B (+$94.5M)

40% less funds holding in top 10

Funds holding in top 10: 10 → 6 (-4)

Holders
191
Holders Change
+9
Holders Change %
+4.95%
% of All Funds
5.54%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.17%
New
48
Increased
77
Reduced
61
Closed
37
Calls
$31.4M
Puts
$27.1M
Net Calls
+$4.31M
Net Calls Change
+$5.63M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$46.5M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$44.3M
3
PCM
Penn Capital Management
Pennsylvania
+$30.2M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$29.9M
5
Wells Fargo
Wells Fargo
California
+$28.7M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$43.1M
2
Millennium Management
Millennium Management
New York
-$26.3M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$26.1M
4
CWAM
Columbia Wanger Asset Management
Illinois
-$22.3M
5
TI
Turner Investments
Pennsylvania
-$20.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
76
New York State Common Retirement Fund
New York
$4.71M +$4.27M +155,113 New
Two Sigma Advisers
77
Two Sigma Advisers
New York
$4.52M -$13.1M -477,200 -76%
FWIA
78
Fort Washington Investment Advisors
Ohio
$4.44M -$881K -32,000 -18%
PAMU
79
Pictet Asset Management (UK)
United Kingdom
$4.29M +$116K +4,200 +3%
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
$3.91M -$5.2M -188,835 -59%
SFM
81
Sphera Funds Management
Israel
$3.89M +$3.53M +128,000 New
RhumbLine Advisers
82
RhumbLine Advisers
Massachusetts
$3.79M +$71.3K +2,590 +2%
SCA
83
SAC Capital Advisors
Connecticut
$3.74M +$478K +17,344 +16%
MSA
84
Mason Street Advisors
Wisconsin
$3.6M -$1.74M -63,360 -35%
WMSA
85
Weiss Multi-Strategy Advisers
New York
$3.38M +$1.42M +51,460 +86%
CCMH
86
Cornerstone Capital Management Holdings
New York
$3.33M +$2.07M +75,300 +218%
Macquarie Group
87
Macquarie Group
Australia
$3.31M -$576K -20,918 -16%
NI
88
Numeric Investors
Massachusetts
$2.74M +$2.48M +90,200 New
IG
89
ING Group
Netherlands
$2.71M +$162K +5,879 +7%
Asset Management One
90
Asset Management One
Japan
$2.67M +$369K +13,391 +18%
Ohio Public Employees Retirement System (OPERS)
91
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.64M +$2.4M +86,982 New
Swiss National Bank
92
Swiss National Bank
Switzerland
$2.64M +$30.3K +1,100 +1%
SCM
93
Suffolk Capital Management
New York
$2.64M +$2.39M +86,900 New
SB
94
Suntrust Banks
Georgia
$2.62M -$716K -26,001 -23%
AC
95
Ascend Capital
California
$2.51M +$2.27M +82,587 New
TAM
96
Tocqueville Asset Management
New York
$2.46M +$482K +17,500 +27%
KBC Group
97
KBC Group
Belgium
$2.46M +$398K +14,465 +22%
MLICM
98
Metropolitan Life Insurance Company (MetLife)
New York
$2.46M +$9.17K +333 +0.4%
Dimensional Fund Advisors
99
Dimensional Fund Advisors
Texas
$2.45M +$356K +12,933 +19%
AC
100
Amici Capital
New York
$2.43M – – –
2 3
4
5 6

NPSP Hedge Fund Activity: Q4 2013 in Review

191 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q4 2013, worth a combined $2.99B — up 3.3% from $2.89B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new NPSP positions and 37 closed out — a net gain of 11 holders — while 77 added to existing stakes and 61 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $46.5M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $43.1M sold.

  • 191 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q4 2013, up from 182 in Q3 2013.
  • Funds reported $2.99B of NPS PHARMACEUTICALS INC stock for Q4 2013, up 3.3% quarter-over-quarter.
  • 48 funds opened new NPS PHARMACEUTICALS INC positions in Q4 2013 and 37 closed out, a net change of +11 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q4 2013 was AllianceBernstein, an estimated $46.5M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q4 2013 was Consonance Capital Management, an estimated $43.1M sold.

Based on aggregated 13F filings for Q4 2013.